Clinical parameters | Number of patients (%) |
---|---|
Primary patients | 64 |
Sex | Â |
   Male | 41 (64.1) |
   Female | 23 (35.9) |
Age (years old) | Â |
   < 30 | 1 (1.6) |
   30-39 | 10 (15.6) |
   40-49 | 16 (25) |
   50-59 | 27 (42.2) |
   60-69 | 11 (17.2) |
   70-79 | 11 (17.2) |
   ≥ 80 | 2 (3.1) |
Intraoral site | Â |
   Hard palate | 28 (43.8) |
   Maxillary gingiva | 15 (23.4) |
   Mandibular gingiva | 14 (21.9) |
   Buccal mucosa | 3 (4.7) |
   Lip | 3 (4.7) |
   Floor of mouth | 1 (1.6) |
T stage | Â |
   T3 | 53 (82.8) |
   T4a | 11 (17.2) |
N stage | Â |
   cN0 | 38 (59.4) |
   cN1 | 26 (40.6) |
   pN- | 25 (39) |
   pN0 | 3 (4.7) |
   pN1 | 36 (56.3) |
M stage | Â |
   M0 | 62 (96.9) |
   M1 | 2 (3.1) |
Clinical stage | Â |
   III | 22 (34.4) |
   IVA | 40 (62.5) |
   IVC | 2 (3.1) |
Recurrent patients | 14 |
Sex | Â |
   Male | 9 (64.3) |
   Female | 5 (35.7) |
Type of recurrence | Â |
   Intraoral recurrence | 5 (35.7) |
   Intraoral and neck recurrence | 9 (64.3) |